Semmelweis University of Budapest, Heart and Vascular Center, Budapest, Hungary; Bács-Kiskun County Hospital, Cardiology Division, Invasive Cardiology, Kecskemét, Hungary.
Bács-Kiskun County Hospital, Cardiology Division, Invasive Cardiology, Kecskemét, Hungary.
JACC Cardiovasc Interv. 2018 Jun 11;11(11):1062-1071. doi: 10.1016/j.jcin.2018.03.038.
The purpose of this prospective study was to evaluate the acute success and complication rates of combined transradial and transpedal access for femoral artery intervention.
Improved equipment and techniques have resulted in transition from transfemoral to transradial access for intervention of superficial femoral artery.
Between 2014 and 2016, clinical and angiographic data from 145 consecutive patients with symptomatic superficial femoral stenosis, treated via primary radial access using the 6-F SheathLess Eaucath PV guiding catheter were evaluated in a pilot study. Secondary access was achieved through the pedal or popliteal artery. The primary endpoints were major adverse events, target lesion revascularization, and rates of major and minor access-site complications. Secondary endpoints included angiographic outcome, procedural factors, crossover rate to femoral access site, and duration of hospitalization.
Technical success was achieved in 138 patients (95.2%). Combined radial and pedal access was obtained in 22 patients (15.1%). The crossover rate to a femoral access site was 2%. Stent implantation was necessary in 23.4% of patients. Chronic total occlusion recanalization was performed in 63 patients, with a 90.4% technical success rate. The mean contrast consumption, radiation dose, and procedure time were 112.9 ml (101.8 to 123.9 ml), 21.84 Gy/cm (9.95 to 33.72 Gy/cm), and 34.9 min (31.02 to 38.77 min), respectively. The cumulative rate of access-site complications was 4.8% (0% major, 4.8% minor). The cumulative incidence rates of major adverse events at 3 and 12 months follow-up was 8.3% and 19.2%. The cumulative incidence rates of death at 3- and 12-month follow-up were 2.8% and 5.6%.
Femoral artery intervention can be safely and effectively performed using radial and pedal access with acceptable morbidity and a high technical success rate.
本前瞻性研究旨在评估经桡动脉和经足动脉联合入路行股动脉介入治疗的急性成功率和并发症发生率。
改良设备和技术已促使经股动脉入路向经桡动脉入路转变,以用于治疗股浅动脉病变。
2014 年至 2016 年间,对 145 例因症状性股浅动脉狭窄行初次经桡动脉入路、使用 6-F 无鞘 Eaucath PV 引导导管治疗的连续性患者的临床和血管造影资料进行了一项前瞻性研究。采用经皮或腘动脉进行辅助入路。主要终点为主要不良事件、靶病变血运重建以及主要和次要入路部位并发症发生率。次要终点包括血管造影结果、手术相关因素、股动脉入路的转归率以及住院时间。
138 例(95.2%)患者技术上获得成功。22 例(15.1%)患者采用联合桡动脉和足动脉入路。股动脉入路的转归率为 2%。23.4%的患者需要植入支架。63 例患者行慢性完全闭塞再通治疗,技术成功率为 90.4%。平均造影剂用量、辐射剂量和手术时间分别为 112.9ml(101.8 至 123.9ml)、21.84Gy/cm(9.95 至 33.72Gy/cm)和 34.9min(31.02 至 38.77min)。入路部位并发症发生率为 4.8%(0 级主要并发症,4.8%为次要并发症)。3 个月和 12 个月随访时,总的不良事件发生率分别为 8.3%和 19.2%。3 个月和 12 个月时的死亡率分别为 2.8%和 5.6%。
采用桡动脉和足动脉入路行股动脉介入治疗安全、有效,并发症发生率低,技术成功率高。